• SCIENTIFIC NAMES: Artemisia annua; Benflumetol; Co-artemether; Coartem; Riamet (Novartis)
  • INDICATIONS: Fever, multidrug-resistant malaria, parasitemia, leukemia, colon cancer, diarrhea, schistosomiasis, worms, insect bites (topical)
  • SYNONYM: Asteraceae
  • CLASS: Antimalarial
  • HALF-LIFE: 10 hours
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    None known

This drug profile only refers to Artemisia annua, NOT Artemisia absinthium. The latter, the main constituent of absinthe, has serious side effects, including seizures, hallucinations, and death.

Derivatives of Artemisia annua are often used in combination with piperaquine, or mefloquine in treatment of malaria. Benflumetol, Coartem and Co-artemether are a combination of artemether-lumefantrine (see separate profile).

Please login to view the rest of this drug profile.

Page last updated 07/31/2023

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric